Persistence of Upper-Airway Symptoms During CPAP Compromises Adherence at 1 Year

References

1. 1.↵
   1. Giles TL,
   2. Lasserson TJ,
   3. Smith BH,
   4. White J,
   5. Wright J,
   6. Cates CJ

   . Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006;(3):CD001106.
2. 2.↵
   1. Kakkar RK,
   2. Berry RB

   . Positive airway pressure treatment for obstructive sleep apnea. Chest 2007;132(3):1057–1072.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. McDaid C,
   2. Durée KH,
   3. Griffin SC,
   4. Weatherly HL,
   5. Stradling JR,
   6. Davies RJ,
   7. et al

   . A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Med Rev 2009;13(6):427–436.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Meslier N,
   2. Lebrun T,
   3. Grillier-Lanoir V,
   4. Rolland N,
   5. Henderick C,
   6. Sailly JC,
   7. Racineux JL

   . A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J 1998;12(1):185–192.

   OpenUrlAbstract
5. 5.↵
   1. Pépin JL,
   2. Leger P,
   3. Veale D,
   4. Langevin B,
   5. Robert D,
   6. Lévy P

   . Side effects of nasal continuous positive airway pressure in sleep apnea syndrome: study of 193 patients in two French sleep centers. Chest 1995;107(2):375–381.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Brander PE,
   2. Soirinsuo M,
   3. Lohela P

   . Nasopharyngeal symptoms in patients with obstructive sleep apnea syndrome: effect of nasal CPAP treatment. Respiration 1999;66(2):128–135.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Baltzan MA,
   2. Elkholi O,
   3. Wolkove N

   . Evidence of interrelated side effects with reduced compliance in patients treated with nasal continuous positive airway pressure. Sleep Med 2009;10(2):198–205.

   OpenUrlPubMed
8. 8.↵
   1. Kreivi HR,
   2. Virkkula P,
   3. Lehto J,
   4. Brander P

   . Frequency of upper airway symptoms before and during continuous positive airway pressure treatment in patients with obstructive sleep apnea syndrome. Respiration 2010;80(6):488–494.

   OpenUrlPubMed
9. 9.↵
   1. Martins De Araújo MT,
   2. Vieira SB,
   3. Vasquez EC,
   4. Fleury B

   . Heated humidification or face mask to prevent upper airway dryness during continuous positive airway pressure therapy. Chest 2000;117(1):142–147.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Massie CA,
    2. Hart RW,
    3. Peralez K,
    4. Richards GN

    . Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest 1999;116(2):403–408.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.
    1. Neill AM,
    2. Wai HS,
    3. Bannan SP,
    4. Beasley CR,
    5. Weatherall M,
    6. Campbell AJ

    . Humidified nasal continuous positive airway pressure in obstructive sleep apnoea. Eur Respir J 2003;22(2):258–262.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Ryan S,
    2. Doherty LS,
    3. Nolan GM,
    4. McNicholas WT

    . Effects of heated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sleep apnea syndrome using nasal continuous positive airway pressure. J Clin Sleep Med 2009;5(5):422–427.

    OpenUrlPubMedWeb of Science
13. 13.↵
    1. Mador MJ,
    2. Krauza M,
    3. Pervez A,
    4. Pierce D,
    5. Braun M

    . Effect of heated humidification on compliance and quality of life in patients with sleep apnea using nasal continuous positive airway pressure. Chest 2005;128(4):2151–2158.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Worsnop CJ,
    2. Miseski S,
    3. Rochford PD

    . Routine use of humidification with nasal continuous positive airway pressure. Intern Med J 2010;40(9):650–656.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Bachour A,
    2. Virkkala JT,
    3. Maasilta PK

    . AutoCPAP initiation at home: optimal trial duration and cost-effectiveness. Sleep Med 2007;8(7):704–710.

    OpenUrlPubMed
16. 16.↵
    1. Kreivi HR,
    2. Virkkula P,
    3. Lehto JT,
    4. Brander PE

    . Upper airway symptoms in primary snoring and in sleep apnea. Acta Otolaryngol 2012;132(5):510–518.

    OpenUrlPubMed
17. 17.↵
    1. Lojander J,
    2. Brander PE,
    3. Ammälä K

    . Nasopharyngeal symptoms and nasal continuous positive airway pressure therapy in obstructive sleep apnoea syndrome. Acta Otolaryngol 1999;119(4):497–502.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Mortimore IL,
    2. Bradley PA,
    3. Murray JA,
    4. Douglas NJ

    . Uvulopalatopharyngoplasty may compromise nasal CPAP therapy in sleep apnea syndrome. Am J Respir Crit Care Med 1996;154(6 Pt 1):1759–1762.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Bachour A,
    2. Maasilta P

    . Mouth breathing compromises adherence to nasal continuous positive airway pressure therapy. Chest 2004;126(4):1248–1254.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Guggenheimer J,
    2. Moore PA

    . Xerostomia: etiology, recognition and treatment. J Am Dent Assoc 2003;134(1):61–69.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Bachour A,
    2. Vitikainen P,
    3. Virkkula P,
    4. Maasilta P

    . CPAP interface: satisfaction and side effects. Sleep Breath 2013;17(2):667–672.

    OpenUrlPubMed